Harrow Adds Another Piece To Ophthalmology Strategy

Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1%, a prescription treatment for vernal keratoconjunctivitis (VKC), a serious allergic eye condition that primarily affects children. The eye care company...

Why Is SanDisk Stock Gaining Thursday?

SanDisk Corporation (NASDAQ:SNDK) stock climbed nearly 6% on Thursday as investors continued to favor high-growth technology stocks amid a broader risk-on market environment. SanDisk continues to benefit from the AI infrastructure buildout, as rising demand for...